✦ LIBER ✦

Effects of ZD6474, an orally active inhibitor of VEGF receptor tyrosine kinase, in patients with solid tumors: Results from a phase I study

✍ Scribed by S. Holden; S. Eckhardt; R. Basser; D. Rischin; H. Hurwitz; R. DeBoer; M. Rosenthal; H. Swaisland; M. McKinley; L. Schacter

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-359 Results from a phase I study of th

✍ Wheeler, Catherine; Minami, Hironobu; Ebi, Hiromichi; Tahara, Makoto; Sasaki, Ya 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 189 KB

Phase I clinical trial of CEP-2563 dihyd

✍ Samir D. Undevia; Nicholas J. Vogelzang; Ann M. Mauer; Linda Janisch; Sridhar Ma 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 147 KB

137 A phase I study of an oral vascular

✍ Tolcher, A.; O'Leary, J.J.; DeBono, J.; Molpus, K.; Woodard, C.; Warnat, M.; Lia 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 148 KB

Phase I study of icotinib hydrochloride

✍ Zhao, Qiong; Shentu, Jianzhong; Xu, Nong; Zhou, Jianya; Yang, Guangdie; Yao, Yin 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 498 KB

108 POSTER Phase I study of ABT869, a mu

✍ B.C. Goh; C.H. Thang; N. Sukri; C.I. Wong; R. Soo; R. Carr; S.C. Lee; C.S. Chen; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Phase I and pharmacokinetic study of TSU

✍ Yutaka Ueda; Tatsu Shimoyama; Haruyasu Murakami; Noboru Yamamoto; Yasuhide Yamad 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 472 KB